BEIJING, June 4, 2012 /PRNewswire-Asia-FirstCall/ -- China
Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the
"Company"), one of the leading plasma-based biopharmaceutical
companies in the People's Republic of
China, today announced that it will participate in the
Jefferies 2012 Global Healthcare Conference on June 7, 2012 in New
York.
Mr. Ming Yin, China Biologic's
Vice President of Business Development, will present at the
conference on Thursday, June 7 at
10:00 a.m. in Ballroom 1 at the Grand
Hyatt New York Hotel, 109 East 42nd Street at Grand Central
Terminal, New York.
Investors interested in meeting with China Biologic during the
conference may contact their Jefferies representative.
About China Biologic Products, Inc.
China Biologic Products, Inc., through its indirect
majority-owned subsidiaries, Shandong Taibang Biological Products
Co., Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd. and its
equity investment in Xi'an Huitian Blood Products Co., Ltd., is one
of the leading plasma-based biopharmaceutical companies in
China.
China Biologic is a fully integrated biologic products company
with plasma collection, production and manufacturing, research and
development, and commercial operations. The Company's plasma-based
biopharmaceutical products are irreplaceable during medical
emergencies and are used for the prevention and treatment of
various diseases. The Company sells its products to hospitals and
other healthcare facilities in China. Please see the Company's website
www.chinabiologic.com for additional information.
Company contact:
Mr. Ming Yin
Vice President - Business Development
China Biologic Products, Inc.
Telephone: +86 10 6598 3099
Email: ir@chinabiologic.com
www.chinabiologic.com
SOURCE China Biologic Products, Inc.